Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor

Authors

Carine M Lama, Washington University School of Medicine in St. Louis
Miguel A Hernandez-Rovira, Washington University School of Medicine in St. Louis
Neha Mehta-Shah, Washington University School of Medicine in St. Louis
Aaron Russell, Washington University School of Medicine in St. Louis
Amy C M Musiek, Washington University School of Medicine in St. Louis

Journal

JAAD Case Reports

Publication Date

8-1-2023

Volume

38

First Page

64

Last Page

67

Document Type

Open Access Publication

DOI

10.1016/j.jdcr.2023.06.009

Rights and Permissions

Lama CM, Hernandez-Rovira MA, Mehta-Shah N, Russell A, Musiek ACM. Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor. JAAD Case Rep. 2023 Jun 17;38:64-67. doi: 10.1016/j.jdcr.2023.06.009. Copyright 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Lama, Carine M; Hernandez-Rovira, Miguel A; Mehta-Shah, Neha; Russell, Aaron; and Musiek, Amy C M, "Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor." JAAD Case Reports. 38, 64 - 67. (2023).
https://digitalcommons.wustl.edu/oa_4/2672

Department

ICTS (Institute of Clinical and Translational Sciences)